Immunogenic death of colon cancer cells treated with oxaliplatin

2009/11/02 by Antoine Tesnière, A Tesniere, F. Schlemmer +31 · 8 citations
Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Drug Transport and Resistance Mechanisms #Immunotherapy and Immune Responses

paper · doi:10.1038/onc.2009.356

openalex publication_date 2009/11/02 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Citations

• The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

Cited by

• Molecular mechanisms of cisplatin resistance
• Engineering oxaliplatin( iv ) prodrugs with monohaloacetates for redox-responsive and multimodal anticancer activity
• Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
• TIM3 in COVID-19; A potential hallmark?
• Nanotechnology for Multimodal Synergistic Cancer Therapy
• Immunogenic cell death in cancer and infectious disease
• 7296 地方都市における鉄道駅周辺の土地利用変遷と駅利用動向に関する研究(緑と土地利用,都市計画)
• Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy